A detailed history of Bowen Hanes & CO Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Bowen Hanes & CO Inc holds 117,816 shares of TMO stock, worth $61.9 Million. This represents 1.92% of its overall portfolio holdings.

Number of Shares
117,816
Previous 118,621 0.68%
Holding current value
$61.9 Million
Previous $65.6 Million 11.09%
% of portfolio
1.92%
Previous 1.82%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$531.86 - $624.21 $428,147 - $502,489
-805 Reduced 0.68%
117,816 $72.9 Million
Q2 2024

Aug 12, 2024

SELL
$541.52 - $599.02 $284,298 - $314,485
-525 Reduced 0.44%
118,621 $65.6 Million
Q1 2024

May 13, 2024

BUY
$528.82 - $599.43 $157,059 - $178,030
297 Added 0.25%
119,146 $69.2 Million
Q4 2023

Feb 12, 2024

BUY
$431.41 - $532.94 $128,128 - $158,283
297 Added 0.25%
118,849 $63.1 Million
Q3 2023

Nov 13, 2023

BUY
$498.29 - $574.41 $1.26 Million - $1.45 Million
2,521 Added 2.17%
118,552 $60 Million
Q2 2023

Aug 14, 2023

BUY
$508.46 - $591.13 $179,994 - $209,260
354 Added 0.31%
116,031 $60.5 Million
Q1 2023

May 11, 2023

SELL
$535.0 - $604.82 $881,145 - $996,138
-1,647 Reduced 1.4%
115,677 $66.7 Million
Q4 2022

Feb 09, 2023

BUY
$484.71 - $571.37 $1.11 Million - $1.31 Million
2,296 Added 2.0%
117,324 $64.6 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $3 Million - $3.57 Million
-5,907 Reduced 4.88%
115,028 $58.3 Million
Q2 2022

Aug 12, 2022

SELL
$500.9 - $612.21 $493,386 - $603,026
-985 Reduced 0.81%
120,935 $65.7 Million
Q1 2022

May 12, 2022

SELL
$524.0 - $644.92 $7.28 Million - $8.95 Million
-13,885 Reduced 10.22%
121,920 $72 Million
Q4 2021

Feb 11, 2022

SELL
$569.0 - $667.24 $6.27 Million - $7.35 Million
-11,016 Reduced 7.5%
135,805 $90.6 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $1.39 Million - $1.66 Million
-2,724 Reduced 1.82%
146,821 $83.9 Million
Q2 2021

Aug 12, 2021

SELL
$441.0 - $508.24 $712,215 - $820,807
-1,615 Reduced 1.07%
149,545 $75.4 Million
Q1 2021

May 13, 2021

SELL
$439.85 - $518.83 $439,410 - $518,311
-999 Reduced 0.66%
151,160 $69 Million
Q4 2020

Feb 08, 2021

SELL
$435.06 - $527.66 $4.18 Million - $5.06 Million
-9,597 Reduced 5.93%
152,159 $70.9 Million
Q3 2020

Feb 08, 2021

SELL
$359.77 - $441.52 $359 - $441
-1 Reduced -0.0%
161,756 $71.4 Million
Q3 2020

Nov 02, 2020

SELL
$359.77 - $441.52 $813,799 - $998,718
-2,262 Reduced 1.38%
161,757 $71.4 Million
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $914,489 - $1.2 Million
-3,323 Reduced 1.99%
164,019 $59.4 Million
Q1 2020

May 14, 2020

SELL
$255.3 - $340.05 $168,498 - $224,433
-660 Reduced 0.39%
167,342 $47.5 Million
Q4 2019

Feb 13, 2020

SELL
$271.93 - $328.04 $4.07 Million - $4.91 Million
-14,975 Reduced 8.18%
168,002 $54.6 Million
Q3 2019

Nov 13, 2019

SELL
$268.46 - $305.43 $6.59 Million - $7.5 Million
-24,555 Reduced 11.83%
182,977 $53.3 Million
Q2 2019

Aug 13, 2019

BUY
$257.51 - $295.55 $75,965 - $87,187
295 Added 0.14%
207,532 $60.9 Million
Q1 2019

May 13, 2019

BUY
$212.17 - $273.72 $1.14 Million - $1.47 Million
5,369 Added 2.66%
207,237 $56.7 Million
Q4 2018

Feb 13, 2019

SELL
$208.47 - $251.98 $310,828 - $375,702
-1,491 Reduced 0.73%
201,868 $45.2 Million
Q3 2018

Nov 08, 2018

SELL
$205.57 - $244.32 $158,905 - $188,859
-773 Reduced 0.38%
203,359 $49.6 Million
Q2 2018

Aug 14, 2018

SELL
$203.14 - $219.53 $2.23 Million - $2.41 Million
-10,971 Reduced 5.1%
204,132 $42.3 Million
Q1 2018

May 15, 2018

SELL
$192.98 - $224.11 $376,311 - $437,014
-1,950 Reduced 0.9%
215,103 $44.4 Million
Q4 2017

Feb 13, 2018

SELL
$182.03 - $200.37 $155,635 - $171,316
-855 Reduced 0.39%
217,053 $41.2 Million
Q3 2017

Nov 13, 2017

BUY
$171.74 - $194.04 $37.4 Million - $42.3 Million
217,908
217,908 $41.2 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $206B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Bowen Hanes & CO Inc Portfolio

Follow Bowen Hanes & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bowen Hanes & CO Inc with notifications on news.